Older emergency department head trauma patients appear to have a very low incidence of delayed intracranial hemorrhage (ICH) after head injury, with no difference in rates based on prior anticoagulant ...

Report on how AI is driving market transformation - The global heparin market size is estimated to grow by USD 3.34 billion ...

The drug Enoxaparin is used for anti-coagulation once there is clot formation in any part of the body. More commonly, it’s ...

Objective After transcatheter aortic valve implantation (TAVI), the optimal regimen of anticoagulant therapy in patients with an additional indication for oral anticoagulation remains a matter of ...

Management of HIT requires the immediate cessation of all heparin exposure, and the initiation of an alternative anticoagulant. Because r-hirudins are effective agents and do not cross-react with ...

Heparin‑induced thrombocytopenia (HIT) is an adverse drug reaction with significant thromboembolic risk. Though there are models for use of nonheparin anticoagulants, heparin remains the preferred ...

and novel oral anticoagulants (NOACs) were the two most effective drugs. For treatment, low molecular weight heparin (LMWH), unfractionated heparin (UFH), and vitamin K antagonists (VKAs) ...

Study performed at the Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.

Doctors need to know which cases are directly linked to heparin so they can switch those patients to another blood thinner. That said, non-heparin anticoagulants are expensive and hard to monitor, so ...